Q1 2026 Holdings
Filed 2026-05-14 | 93 holdings | $2.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $297.9M | 1,153,087 | 12.1% |
| Celcuity Inc(CELC) | COM | 15102K100 | $146.6M | 1,284,378 | 5.9% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $133.9M | 4,029,319 | 5.4% |
| Insulet Corp(PODD) | COM | 45784P101 | $118.0M | 562,500 | 4.8% |
| Novocure LTD(NVCR) | ORD SHS | G6674U108 | $114.4M | 10,492,391 | 4.6% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $111.0M | 187,187 | 4.5% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $106.5M | 330,517 | 4.3% |
| Vericel Corp(VCEL) | COM | 92346J108 | $82.0M | 2,549,079 | 3.3% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $69.7M | 1,970,864 | 2.8% |
| ANI Pharmaceuticals Inc(ANIP) | COM | 00182C103 | $63.1M | 820,243 | 2.6% |
| Globus MED Inc(GMED) | CL A | 379577208 | $62.9M | 729,467 | 2.5% |
| Geron Corp(GERN) | COM | 374163103 | $61.8M | 41,508,659 | 2.5% |
| Twist Bioscience Corp(TWST) | COM | 90184D100 | $58.3M | 1,226,629 | 2.4% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $45.7M | 1,449,915 | 1.8% |
| Beta Bionics Inc(BBNX) | COM | 08659B102 | $43.6M | 4,354,501 | 1.8% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $43.6M | 131,650 | 1.8% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $40.3M | 1,726,908 | 1.6% |
| Indivior Pharmaceuticals Inc(INDV) | COM | 45579U109 | $38.8M | 1,274,000 | 1.6% |
| Neuropace Inc(NPCE) | COM | 641288105 | $38.6M | 2,932,207 | 1.6% |
| Livanova PLC(LIVN) | SHS | G5509L101 | $37.0M | 582,500 | 1.5% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $37.0M | 400,306 | 1.5% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $36.8M | 650,572 | 1.5% |
| Progyny Inc(PGNY) | COM | 74340E103 | $35.1M | 2,067,000 | 1.4% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $29.7M | 576,299 | 1.2% |
| Edap TMS S A(EDA) | SPONSORED ADR | 268311107 | $27.2M | 7,309,254 | 1.1% |
| Kiniksa Pharmaceuticals Intl(KNSA) | ORD SHS CL A | G52694109 | $25.1M | 521,353 | 1.0% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $24.4M | 203,000 | 1.0% |
| Organogenesis Hldgs Inc(ORGO) | COM | 68621F102 | $23.9M | 10,085,951 | 1.0% |
| Natera Inc(NTRA) | COM | 632307104 | $23.8M | 119,000 | 1.0% |
| Axogen Inc(AXGN) | COM | 05463X106 | $22.5M | 679,170 | 0.9% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $22.4M | 385,472 | 0.9% |
| Icon PLC(ICLR) | SHS | G4705A100 | $21.2M | 192,000 | 0.9% |
| Pharvaris N V(PHVS) | COM | N69605108 | $19.8M | 702,052 | 0.8% |
| Cerus Corp(CERS) | COM | 157085101 | $19.6M | 10,753,700 | 0.8% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $19.3M | 1,620,000 | 0.8% |
| Inhibikase Therapeutics Inc(IKT) | COM NEW | 45719W205 | $18.3M | 10,875,000 | 0.7% |
| Context Therapeutics Inc(CNTX) | COM | 21077P108 | $18.2M | 6,963,141 | 0.7% |
| VIR Biotechnology Inc(VIR) | COM | 92764N102 | $17.9M | 2,002,000 | 0.7% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $17.0M | 292,000 | 0.7% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $16.2M | 546,000 | 0.7% |
| Tandem Diabetes Care Inc(TNDM) | COM NEW | 875372203 | $15.0M | 783,000 | 0.6% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $14.5M | 938,163 | 0.6% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $13.1M | 727,000 | 0.5% |
| Sionna Therapeutics Inc(SION) | COM | 829401108 | $11.8M | 293,500 | 0.5% |
| Corcept Therapeutics Inc(CORT) | COM | 218352102 | $11.5M | 285,531 | 0.5% |
| Jade Biosciences Inc(JBIO) | COM NEW | 008064206 | $11.2M | 796,744 | 0.5% |
| Veracyte Inc(VCYT) | COM | 92337F107 | $10.3M | 319,912 | 0.4% |
| Invivyd Inc(IVVD) | COM | 00534A102 | $10.0M | 7,708,727 | 0.4% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $10.0M | 3,803,942 | 0.4% |
| Orthopediatrics Corp(KIDS) | COM | 68752L100 | $9.8M | 615,447 | 0.4% |